BONE BIOLOGICS CORPORATION: 10-K filed 2014-02-13
What BONE BIOLOGICS CORPORATION reported in its annual report filed 2014-02-13 (fiscal FY 2013): 13 published measures, 39 facts as tagged in accession 0001493152-14-000445.
This filing
- Form
- 10-K (annual report)
- Filed
- 2014-02-13
- Fiscal period
- fiscal FY 2013
- Accession
- 0001493152-14-000445 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BONE BIOLOGICS CORPORATION filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 380 | USD | |
| At 2012-10-31 | 500 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 40,185 | USD | |
| At 2012-10-31 | 35,099 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | -39,805 | USD | |
| At 2012-10-31 | -34,599 | USD | |
| At 2011-10-31 | -28,968 | USD | |
| At 2010-10-31 | -24,048 | USD | |
| At 2009-10-31 | -20,451 | USD | |
| At 2008-10-31 | -10,166 | USD | |
| At 2007-10-31 | -9,723 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 380 | USD | |
| At 2012-10-31 | 500 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | -5,206 | USD | 365 |
| 2007-10-18 to 2013-10-31 | -64,805 | USD | 2206 |
| 2011-11-01 to 2012-10-31 | -5,631 | USD | 366 |
| 2010-11-01 to 2011-10-31 | -4,920 | USD | 365 |
| 2009-11-01 to 2010-10-31 | -3,597 | USD | 365 |
| 2008-11-01 to 2009-10-31 | -10,285 | USD | 365 |
| 2007-11-01 to 2008-10-31 | -13,343 | USD | 366 |
| 2007-10-18 to 2007-10-31 | -21,823 | USD | 14 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | -6,116 | USD | 365 |
| 2007-10-18 to 2013-10-31 | -61,221 | USD | 2206 |
| 2011-11-01 to 2012-10-31 | -6,057 | USD | 366 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | 5,996 | USD | 365 |
| 2007-10-18 to 2013-10-31 | 61,601 | USD | 2206 |
| 2011-11-01 to 2012-10-31 | 6,557 | USD | 366 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 64,805 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2007-10-18 to 2013-10-31 | 15 | USD | 2206 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | 4,806 | USD | 365 |
| 2007-10-18 to 2013-10-31 | 63,405 | USD | 2206 |
| 2011-11-01 to 2012-10-31 | 5,231 | USD | 366 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 5,000,000 | shares | |
| At 2012-10-31 | 5,000,000 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-10-31 | 20,000 | USD | |
| At 2012-10-31 | 20,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-11-01 to 2013-10-31 | -4,806 | USD | 365 |
| 2007-10-18 to 2013-10-31 | -63,405 | USD | 2206 |
| 2011-11-01 to 2012-10-31 | -5,231 | USD | 366 |
Inspect the source
- Entity
- BONE BIOLOGICS CORPORATION / CIK 0001419554
- Captured
- 2026-09-20T08:02:52.100Z
- SEC response SHA-256
7c2684db7febb4ea6b03577e138dc91ed20e12534f1d96c178894d4b68a7b815
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001419554.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))